Obesity and impaired reproductive potential
The adverse consequence of stoutness upon fruitfulness was portrayed by Hippocrates, who wrote in his Essay on the Scythians 'Individuals of such constitution can't be productive ,bloatedness and heaviness are to be faulted. The belly can't get the semen and they bleed rarely and little' (Lloyd et al. 1978). Putative foundations for origination delay in fat ladies can thoughtfully be arranged as pathophysiological, psychosocial and sociobiological. The heft of this article will relate to the pathophysiological viewpoints. Nonetheless, the psychosocial and sociobiological perspectives will addressed toward the finish of this part. A few populace based investigations have shown subfecundity in overweight and hefty ladies. The Nurses ‘Health Study thought about 2527 wedded nulliparous ladies with anovulatory subfertility of 1 year with 46 718 wedded multiparous ladies with no set of experiences of subfertility. Multivariate examination decided the family member hazard of fruitlessness for every BMI class, and the family member hazards were accounted for as follows: 1.2 (BMI !16 kg/m2 ), 1.1 (BMI 16–17.9 kg/m2 ), 1.0 (BMI 18–19.9 kg/m2 ), 1.0 (referent BMI 20–21.9 kg/m2 ), 1.1 (BMI 22–23.9 kg/m2 ), 1.3 (BMI 24–25.9 kg/m2 ), 1.7 (BMI 26–27.9 kg/m2 ), 2.4 (BMI 28–29.9 kg/m2 ), 2.7 (BMI 30–31.9 kg/m2 ) and 2.7 (BMI R32 kg/m2 ). Consequently, above 23.9, the family member hazard of subfertility was measurably altogether raised. Essentially, a higher commonness of anovulatory subfertility among the hefty ladies. They looked at 597 anovulatory ladies with 1695 primiparous controls; the general danger of anovulatory subfertility in the fat ladies (characterized in this examination as BMI O27 kg/m2) was 3.1 (95% certainty stretch (CI) 2.2–4.4) when contrasted with those with an ordinary BMI (20–24.9 kg/m2 ). A comparable impact has been shown in an observational investigation of 2112 sequential pregnant ladies to research way of life factors that may hinder fruitfulness, and a BMI O25 kg/m2 was altogether associated with a prolongation of time to pregnancy.
- Mitochondrial replacement therapy
- In vitro fertilization
Related Conference of Obesity and impaired reproductive potential
24th International Conference on Obesity, Diet Management & Nutrition
Obesity and impaired reproductive potential Conference Speakers
Recommended Sessions
- Obesity as a medical problem
- Causes of obesity
- Childhood Obesity
- Molecular Mechanism of Insulin Resistance and Obesity
- Obesity
- Obesity and impaired reproductive potential
- Obesity and PCOS
- Obesity and respiratory diseases
- Obesity and the Environment: Where Do We Go from Here?
- Obesity as a pandemic
- Obesity in women from developing countries
- Obesity Physiotherapy
- Obesity: a growing issue for European policy?
- Obesity: its effect upon the embryo, uterus and ovaries
- Pathology of excess fat
- Social Factors in Obesity
- The adverse effects of obesity on conception and implantation
- The epidemiology of obesity
- Update on Obesity
- Who pays for obesity
Related Journals
Are you interested in
- Advanced Treatment for Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Advances in Obesity Pathophysiology - Obesity_2026 (UK)
- Anti-Obesity Drugs - OBESITY MEDICINE 2026 (Netherlands)
- Anti-Obesity Pharmacotherapy - Obesity_2026 (UK)
- Bariatric Surgery - OBESITY MEDICINE 2026 (Netherlands)
- Bariatric Surgery & Post-Operative Care - Obesity_2026 (UK)
- Bariatric Surgery: Advances and Outcomes - Obesity-2026 (UK)
- Cardiovascular Complications of Obesity - Obesity_2026 (UK)
- Childhood and Adolescent Obesity - Obesity-2026 (UK)
- Childhood and Adolescent Obesity - Obesity_2026 (UK)
- Childhood Obesity and Nutrition - OBESITY MEDICINE 2026 (Netherlands)
- Childhood Obesity Risk Factors - Childhood Obesity 2026 (France)
- Clinical Nutrition and Evidence-Based Dietetics - Obesity-2026 (UK)
- Clinical Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Current Research on Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Diabetes, Endocrinology and Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Diabetes, Obesity, and Endocrine Health - Obesity-2026 (UK)
- Diet & Nutrition - OBESITY MEDICINE 2026 (Netherlands)
- Diet Management for Weight Loss and Long-Term Health - Obesity-2026 (UK)
- Dietary and Lifestyle Changes - OBESITY MEDICINE 2026 (Netherlands)
- Digital Health, Wearables & AI in Obesity Management - Obesity_2026 (UK)
- Digital Tools for Childhood Wellness - Childhood Obesity 2026 (France)
- Early-Life Nutrition & Growth - Childhood Obesity 2026 (France)
- Endocrine Disorders & Hormonal Imbalance - Obesity_2026 (UK)
- Family & Community Nutrition Strategies - Childhood Obesity 2026 (France)
- Food Environment & Behavioral Choices - Childhood Obesity 2026 (France)
- Food Industry, Marketing & Consumer Behavior - Obesity_2026 (UK)
- Functional Foods, Nutraceuticals, and Dietary Supplements - Obesity-2026 (UK)
- Genetics and Epigenetics of Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Genetics, Epigenetics & Obesity Risk - Obesity_2026 (UK)
- Global Trends in Childhood Nutrition - Childhood Obesity 2026 (France)
- Gut Microbiome & Metabolic Health - Obesity_2026 (UK)
- Gut Microbiome, Nutrition, and Metabolic Health - Obesity-2026 (UK)
- Gynaecology & Obstetrics - OBESITY MEDICINE 2026 (Netherlands)
- Healthy Dietary Patterns in Children - Childhood Obesity 2026 (France)
- Innovations in Pediatric Dietetics - Childhood Obesity 2026 (France)
- Lifestyle Modifications & Behavioral Therapy - Obesity_2026 (UK)
- Liposuction and Weight Loss Treatments - OBESITY MEDICINE 2026 (Netherlands)
- Medical Nutrition Therapy for Chronic Diseases - Obesity-2026 (UK)
- Metabolic Syndrome and Obesity-Related Disorders - Obesity-2026 (UK)
- Micronutrient Needs in Childhood - Childhood Obesity 2026 (France)
- Non-Surgical Treatment for Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Nutrigenomics and Nutrigenetics - Obesity-2026 (UK)
- Nutrition, Dietetics & Weight Management - Obesity_2026 (UK)
- Nutritional Interventions for Obesity - Childhood Obesity 2026 (France)
- Obesity & Associated Health Disorders - OBESITY MEDICINE 2026 (Netherlands)
- Obesity & Cancer - OBESITY MEDICINE 2026 (Netherlands)
- Obesity & Cardiometabolic Syndrome - Obesity_2026 (UK)
- Obesity & Liver Disorders (NAFLD/NASH) - Obesity_2026 (UK)
- Obesity and Cancer Risk - Obesity_2026 (UK)
- Obesity and Cardiovascular Diseases - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Chronic Diseases - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Diabetes Interlink - Obesity_2026 (UK)
- Obesity and Eating Disorders - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Mental Health - Obesity_2026 (UK)
- Obesity and Metabolic Diseases - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Weight Loss - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Weight Management - OBESITY MEDICINE 2026 (Netherlands)
- Obesity Causes - OBESITY MEDICINE 2026 (Netherlands)
- Obesity in Aging Populations - Obesity_2026 (UK)
- Obesity in Women - OBESITY MEDICINE 2026 (Netherlands)
- Obesity in Women’s Health - Obesity_2026 (UK)
- Obesity Prevention - OBESITY MEDICINE 2026 (Netherlands)
- Obesity: Global Trends, Prevention, and Public Health - Obesity-2026 (UK)
- Pediatric Gut Health & Nutrition - Childhood Obesity 2026 (France)
- Pediatric Metabolic Health - Childhood Obesity 2026 (France)
- Personalized Nutrition and Precision Dietetics - Obesity-2026 (UK)
- Physical Activity & Lifestyle Behaviors - Childhood Obesity 2026 (France)
- Physical Activity, Exercise & Fitness Science - Obesity_2026 (UK)
- Physical Activity, Exercise & Kinesiology - OBESITY MEDICINE 2026 (Netherlands)
- Policy Approaches to Childhood Obesity - Childhood Obesity 2026 (France)
- Public Health Strategies & Community Interventions - Obesity_2026 (UK)
- Role of Steroids and Hormones in Obesity - OBESITY MEDICINE 2026 (Netherlands)
- School-Based Nutrition Programs - Childhood Obesity 2026 (France)
- Yoga and Naturopathy - OBESITY MEDICINE 2026 (Netherlands)
